Product Details:
|
Product Name: | Myoglobin (Myo) Test Kit (TRFIA) | Type: | Immunoassay System |
---|---|---|---|
Function: | Cardiac Marker | Usage: | Vitro Diagnostic Reagent For Professional Test |
Specimen: | Whole Blood, Plasma, Serum | Storing Temperature: | 2℃-8℃ |
Shelf Life: | 18 Months | Compatible Equipment: | Lumigenex TRFIA Analyzer LTRIC-600, LTRIC-1000 |
High Light: | Cardiac Marker Myo Test Kit,Cardiac Marker Myoglobin Test Kit,Myoglobin Test Kit CE Certificate |
Cardiac Marker Myoglobin (Myo) Test Kit By TRFIA Technology CE Certificate
High sensitivity MYO Quantitative Detection Kit (TRFIA)
CE Certificated
Product Description
1. As myocardial infarction (AMI) early detection indicator, highly sensitive
2. Peaked 1-3h after the onset
3. Diagnose reinfarction or infarct extension
4. Determine myocardial re-perfusion
Advantages
1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography
2. Quantitative: quantitative detection of myocardial infarction marker myoglobin (MYO)
3. Reliable: well correlated with imported chemiluminescence reagent (r> 0.975)
4. High sensitivity: lower detection limit <1.0 ng/mL
5. Easy: ideal for bedside detection with simple operation
6. Widely applicable: outpatient laboratory, emergency room, lab, hospital, medical center, cardiology, intensive care unit, etc
Intended Use
This Myoglobin (MYO) Detect Kit (TRFIA) is appropriate for the in vitro quantitative detection of human serum, plasma, and whole blood myoglobin (abbreviated as MYO hereunder).
An early indicator of cardiac necrosis is myoglobin. MYO can be found within an hour of the commencement and peaks in 4–5 hours, according to clinical trials. MYO levels do, however, rise often in conditions including skeletal muscle damage, neuromuscular or skeletal muscle dysfunction, cardiac shunt surgery, renal failure, and intense exercise. Therefore, the elevation of myoglobin must be used in the auxiliary diagnosis of acute myocardial infarction (AMI) together with the detection of other cardiac markers, electrocardiogram (ECG), clinical symptoms and signs, etc. The detection platform of this project mainly includes chemiluminescence technology, immunocompetency technology, colloidal gold technology, immunofluorescence technology, time-resolved fluorescence technology, and so on.
Specification
High sensitivity cFDA approved MYO Quantitative Detection Kit (TRFIA) Main component
The reagent card consists of plastic casings and test strips, A sample pad, a marker pad (with a mouse anti-human myoglobin (MYO) monoclonal antibody nano-microsphere fluorescent probe (0.5% micro-sphere solid content), detection of membrane (monoclonal antibody (1.5 mg/mL) against human myoglobin (MYO) and polyclonal antibody (1.0 mg/mL) against mouse immunoglobulin (IgG). Sample buffer, 290 µL/one person, The main components were phosphate (PBS) buffer of 0.5% calf serum albumin (BSA) and 0.05% preservative Proclin-300( are 2-methyl-4-isothiazoline-3-one and 5-chloro-2-methyl-4-isothiazoline-3-one).
Myoglobin (MYO) Test Kit (Time-Resolved Fluorescence Immunochromatographic Assay) : Contains 20/50 reagent cards,1 IC card,1 instruction for use, and 20/50 sample buffers.
Storage conditions and expiry date
The seal-packed test kit can be stored at 2℃~8℃ for 18 months. The test card sealed in the aluminum foil bag package can be stored at a temperature (2℃~30℃) for 30 days if it does not exceed the expiry printed on the aluminum foil bag package. The temperature change during transportation (<37℃) has no effect on product quality. The reagent strip after the aluminum foil bag is unsealed can be stabilized for 1 hour at normal temperature.
Compatible Equipments
Contact Person: Bonnie
Tel: 86-13814877381